A Novel AP4M1 Variant in an Iranian Child with Spastic Paraplegia 50: A Case Report and Molecular Docking Approach
Iranian Journal of Medical Sciences · 2026-01 · 51 (1) · 70-76
DOI: 10.30476/ijms.2025.106981.4128 ↗Kurz gefasst
Fallbericht in der Zeitschrift Iranian Journal of Medical Sciences, 2026-01. Verfasst von Hamed Esmaeil Lashgarian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics and Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran. Hauptthemen laut MEDLINE: Adaptor Protein Complex 4, Spastic Paraplegia, Hereditary, Paraplegia. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Spastic paraplegia 50 (SPG50) is a rare autosomal recessive disorder caused by mutations in the AP4M1 gene (OMIM 602296). It is characterized by spasticity, severe intellectual disability, and delayed or absent speech. The present study reported a case from consanguineous parents, where the affected child presented with intellectual disability, seizures, muscle weakness, and deep white matter hyperintensity. Whole exome sequencing (WES) of the proband identified a novel, homozygous frameshift variant, c.258delG:p.A87Pfs*44, in the AP4M1 gene, which was confirmed by Sanger sequencing. This variant is predicted to cause a large truncation of the protein, leading to a loss of function. Molecular modeling and docking analyses further revealed that the loss of a substantial protein segment disrupts proper intramolecular interactions. A review of the literature on Iranian families with SPG50 yielded few reports, consistent with the disease’s rarity. This study expanded the knowledge of the clinical and genetic features of SPG50 and underscored the importance of this variant for genetic diagnosis and counseling in affected families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics and Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
- Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Madar Medical Genetics Center, Khorramabad, Iran.
Zitieren
APA
Esmaeil Lashgarian, H., Jalalvand, M., Zand, M., Jalalvand, A., Abkhooie, L., Kazemisafa, F., & Khodadadi, H. (2026). A Novel AP4M1 Variant in an Iranian Child with Spastic Paraplegia 50: A Case Report and Molecular Docking Approach. Iranian Journal of Medical Sciences, 51(1), 70-76. https://doi.org/10.30476/ijms.2025.106981.4128
Vancouver
Esmaeil Lashgarian H, Jalalvand M, Zand M, Jalalvand A, Abkhooie L, Kazemisafa F, et al. A Novel AP4M1 Variant in an Iranian Child with Spastic Paraplegia 50: A Case Report and Molecular Docking Approach. Iranian Journal of Medical Sciences. 2026;51(1):70-76. doi:10.30476/ijms.2025.106981.4128
BibTeX
@article{EsmaeilLashgarian2026,
author = {Esmaeil Lashgarian, Hamed and Jalalvand, Masumeh and Zand, Maryam and Jalalvand, Amirmasoud and Abkhooie, Leila and Kazemisafa, Fatemeh and Khodadadi, Hamidreza},
title = {A Novel AP4M1 Variant in an Iranian Child with Spastic Paraplegia 50: A Case Report and Molecular Docking Approach},
journal = {Iranian Journal of Medical Sciences},
year = {2026},
volume = {51},
number = {1},
pages = {70--76},
doi = {10.30476/ijms.2025.106981.4128}
}
EUVIMED